Finance

Lists
0874:HKG
Guangzhou Baiyunshan Pharmaceutical Holdings Company Ord Shs H
13,30 HKD
-0,89%
(-0,12) 1D
15 ოქტ, 16:08:33 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 0874...
Open
13,45 HKD
High
13,45 HKD
Low
13,24 HKD
Mkt. cap
35,97 მლრდ.
Avg. vol.
1,08 მლნ.
Volume
1,12 მლნ.
Dividend
6,49%
Quarterly dividend
0,22 HKD
Ex-dividend date
10 სექ. 2026
P/E ratio
6,26
52-wk high
20,40 HKD
52-wk low
12,74 HKD
EPS
2,12 HKD
Shares outstanding
219,90 მლნ.
No. of employees
26 ათ.
Open
13,45 HKD
High
13,45 HKD
Low
13,24 HKD
Mkt. cap
35,97 მლრდ.
Avg. vol.
1,08 მლნ.
Volume
1,12 მლნ.
Dividend
6,49%
Quarterly dividend
0,22 HKD
Ex-dividend date
10 სექ. 2026
P/E ratio
6,26
52-wk high
20,40 HKD
52-wk low
12,74 HKD
EPS
2,12 HKD
Shares outstanding
219,90 მლნ.
No. of employees
26 ათ.
News stories
From web sources and news partners
About Guangzhou Baiyunshan Pharmaceutical Holdings Company Ord Shs H
CEO-
Employees26,4 ათ.
Founded1 სექ. 1997
Headquarters-
SectorHealth care provider
Websitegybys.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
19,77 მლრდ.
16,05 მლრდ.
23,28 მლრდ.
18,81 მლრდ.
Cost of goods sold
16,58 მლრდ.
14,37 მლრდ.
18,55 მლრდ.
16,29 მლრდ.
Cost of revenue
16,58 მლრდ.
14,37 მლრდ.
18,55 მლრდ.
16,29 მლრდ.
Research and development expenses
158,44 მლნ.
217,91 მლნ.
158,68 მლნ.
184,69 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,88 მლრდ.
2,21 მლრდ.
2,22 მლრდ.
1,83 მლრდ.
Operating expense
2,05 მლრდ.
2,50 მლრდ.
2,55 მლრდ.
2,11 მლრდ.
Total operating expenses
18,63 მლრდ.
16,87 მლრდ.
21,10 მლრდ.
18,40 მლრდ.
Operating income
1,14 მლრდ.
-820,04 მლნ.
2,18 მლრდ.
409,74 მლნ.
Other non operating income
83,07 მლნ.
-100,40 მლნ.
-1,28 მლნ.
-15,15 მლნ.
EBT including unusual items
1,09 მლრდ.
-494,18 მლნ.
2,21 მლრდ.
393,99 მლნ.
EBT excluding unusual items
1,24 მლრდ.
-825,17 მლნ.
2,21 მლრდ.
377,21 მლნ.
Income tax expense
271,49 მლნ.
-156,77 მლნ.
383,93 მლნ.
59,00 მლნ.
Effective tax rate
24,82%
31,72%
17,39%
14,97%
Other operating expenses
-46,93 მლნ.
164,17 მლნ.
91,90 მლნ.
62,67 მლნ.
Net income
793,91 მლნ.
-326,94 მლნ.
1,78 მლრდ.
312,16 მლნ.
Net profit margin
4,02%
-2,04%
7,66%
1,66%
Earnings per share
-
-
-
-
Interest and investment income
117,54 მლნ.
187,01 მლნ.
140,88 მლნ.
97,52 მლნ.
Interest expense
-101,91 მლნ.
-95,60 მლნ.
-103,44 მლნ.
-110,76 მლნ.
Net interest expenses
15,64 მლნ.
91,41 მლნ.
37,44 მლნ.
-13,24 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,29 მლრდ.
-660,36 მლნ.
2,34 მლრდ.
583,55 მლნ.
Gain or loss from assets sale
3,63 მლნ.
-107,74 მლნ.
-
-938,61 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები